Patient and public involvement in reducing health and care research waste

Research Involvement and Engagement

Volumn 4, Issue 1, 2018, Pages

  Minogue, Virginia ^a   Cooke, Mary ^b   Donskoy, Anne Laure ^c   Vicary, Penny ^d   Wells, Bill ^e  

^a Quarry House   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c UNIVERSITY OF THE WEST OF ENGLAND   (United Kingdom)

^d UNIVERSITY OF EAST ANGLIA   (United Kingdom)

^e OXFORD HEALTH NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Implementation; Patient benefit; Patient involvement; Prioritisation; Publication; Reducing research waste; Research design

Indexed keywords

EID: 85061490167     PISSN: None     EISSN: 20567529     Source Type: Journal    
DOI: 10.1186/s40900-018-0087-1     Document Type: Review

References (17)

1. Al-Shahi Salman R, Beller E, Kagan J, Hemminki E, Phillips RS, Savulescu J, Macleod M, Wisely J. Increasing value and reducing waste in biomedical research regulation and management. Lancet. 2014;383:176-85
2. Chalmers I, Glasziou P. Avoidable waste in the production and reporting of research evidence. Lancet. 2009;374(9683):86-9
3. Chalmers I, Bracken MB, Djuibegovic B, Garattini S, Grant J, Gulmezoglu AM, Howells DW, Ionnidis JPA, Oliver S. How to increase value and reduce waste when research priorities are set. Lancet. 2014;383:156-65
4. Chalmers I, Glasziou P. BMJ Blogs. Is 85% of health research really ‘wasted’? 2016. British Medical Journal. http://blogs.bmj.com/bmj/2016/01/14/paulglasziou-and-iain-chalmers-is-85-of-health-research-really-wasted/. Accessed 10 Aug 2016
5. Chan A-W, Song F, Vickers A, Jefferson T, Dickersin K, Gotzsche P, Krumholz H, Ghersi D, Van der Worp H. Increasing value and reducing waste: Addressing inaccessible research. Lancet. 2014;383(9913):257-66
6. Glasziou P, Altman DG, Bossuyt P, Boutron I, Julious S, Michie S, Moher D, Wager E. Reducing waste from incomplete or unusable reports of biomedical research. Lancet. 2014;383:267-76
7. Goldacre B 2013. Bad Pharma: How Medicine is Broken, and How We Can Fix It. Fourth Estate
8. Gøtzsche PC. Deadly medicines and organised crime: How big pharma has corrupted health care. London: Radcliffe Publishing; 2013
9. Ioannidis JPA, Greenland S, Hlatky MA, Khoury MJ, Macleod M, Moher D, Schulz KF, Tibshirani R. Increasing value and reducing waste in research design, conduct, and analysis. Lancet. 2014;383:166-75
10. Minogue V, Wells B. Managing resources and reducing waste in healthcare settings. Nurs Stand. 2016a;30(38):52-8
11. Minogue V, Wells B. Reducing waste in the NHS: An overview of the literature and challenges for the nursing profession. Nurs Manag. 2016b;23(4):20-5
12. Minogue V, Wells B, Brooks A. Difficult conversations? Engaging patients in reducing waste in the commissioning and delivery of health care. Int J Health Governance. 2016;21(2):51-8
13. Minogue V, Wells B 2017. NHS Research and Development management community: Adding value, reducing research waste’. NHS Future Focused Finance Programme
14. Moher D, Glasziou P, Chalmers I, Nasser M, Bossuyt PM, Korevaar A, Graham ID, Ravaud P, Boutron I 2016. Increasing value and reducing waste in biomedical research: Who’s listening? Lancet 2016;387(10027):1573-1586
15. Nasser M, Clarke M, Chalmers I, Brurberg KG, Nykvist H, Lund H, Glasziou P. What are funders doing to minimise waste in research? Lancet. 2017;389
16. National Institute for Health Research 2013. Adding Value in Research. www.nets.nihr.ac.uk/adding-value-in-research
17. Ross JS, Tse T, Zarin DA, Xu H, Zhou L, Krumholz HM. Publication of NIH funded trials registered in ClinicalTrials.gov: Cross sectional analysis. BMJ. 2012;344:d7292.